BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2022 8:29:04 AM | Browse: 313 | Download: 733
 |
Received |
|
2022-01-27 12:45 |
|
Peer-Review Started |
|
2022-01-27 12:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-02-24 06:56 |
|
Revised |
|
2022-03-05 15:38 |
|
Second Decision |
|
2022-07-21 03:10 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-07-26 17:37 |
|
Articles in Press |
|
2022-07-26 17:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-08-22 16:56 |
|
Typeset the Manuscript |
|
2022-08-26 00:40 |
|
Publish the Manuscript Online |
|
2022-09-07 08:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carlo Sposito, Davide Citterio, Matteo Virdis, Carlo Battiston, Michele Droz Dit Busset, Maria Flores and Vincenzo Mazzaferro |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Carlo Sposito, MD, Assistant Professor, Surgeon, HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Via Venezian 1, Milan 20133, Italy. carlo.sposito@istitutotumori.mi.it |
| Key Words |
Liver transplantation; Hepatocellular carcinoma; Immunosuppression; Recurrence; Surgical treatment; Locoregional treatment; Systemic treatment |
| Core Tip |
Hepatocellular carcinoma (HCC) is becoming the most common indication to liver transplantation (LT). The problem of tumor recurrence after LT, that occurs in up to 20% of cases, is becoming of increasing interest. In this paper, we performed a review of the available literature on the topic of HCC recurrence after LT. The best preventive measures still rely on pre-transplant selection criteria, since no dedicated follow up guidelines exist and no post-LT adjuvant treatments are available. When recurrence occurs, the prognosis is poor: However, an aggressive surgical treatment, particularly in case of late recurrence, may provide a significant survival benefit. |
| Publish Date |
2022-09-07 08:29 |
| Citation |
Sposito C, Citterio D, Virdis M, Battiston C, Droz Dit Busset M, Flores M, Mazzaferro V. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World J Gastroenterol 2022; 28(34): 4929-4942 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i34/4929.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i34.4929 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
